Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Anavex Life Sciences Corp. - Common Stock (NQ:AVXL)

8.920 +0.310 (+3.60%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Anavex Life Sciences Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
An Overview of Anavex Life Sciences's Earnings
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Anavex Life Sciences Reports Prolonged Benefit Data Of Blarcamesine In Early Alzheimer's Over 3 Years
Anavex's blarcamesine shows sustained cognitive and functional benefit in early Alzheimer's patients after four years of continuous treatment. 
Via Benzinga
Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?
A hotter-than-expected inflation report initially rattled markets on Wednesday morning, but investors found confidence to buy the dip, helping major indexes recover most losses by midday trading in New... 
Via Benzinga
Topics Economy
Exposures Interest Rates
Earnings Scheduled For May 13, 2025
Via Benzinga
Honda Motor, Rumble, Despegar.com And Other Big Stocks Moving Higher On Monday
Via Benzinga
US Stocks To Open Higher As Wall Street Expects 'Santa Rally' In Shortened Trading Week: MicroStrategy, Palantir, Qualcomm Among Stocks In Focus
U.S. stock futures advanced on Monday as two out of the four major index futures were trading higher in premarket trade. 
Via Benzinga
Dow Jumps Around 500 Points But Records 3rd Straight Weekly Loss: Greed Index Moves To 'Fear' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
Qualcomm, Limoneira And 3 Stocks To Watch Heading Into Monday
Via Benzinga
Earnings Scheduled For December 23, 2024
Via Benzinga
Earnings Scheduled For February 7, 2024
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million. 
Via Benzinga
Anavex Life Sciences Earnings Preview
Via Benzinga
Peering Into Anavex Life Sciences's Recent Short Interest
Via Benzinga
Earnings Scheduled For February 12, 2025
Via Benzinga
Retail Investors Bet On Anavex Lifesciences Stock To Outperform Novavax, Rigel Pharma In Q1 On Alzheimer’s Drug Buzz
The intense retail focus on Anavex reflects a broader market interest in neurodegenerative therapies, especially following disappointing trial results from Cassava Sciences’ simufilam. 
Via Stocktwits
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Kemper To Rally More Than 25%? Here Are 4 Top Analyst Forecasts For Thursday
Via Benzinga
Short-Squeeze Target Anavex Life Sciences Gains Traction
Anavex Life Sciences stock market is set up for a short squeeze that could begin in early 2025 and increase the price by 400% or more. 
Via MarketBeat
Greenfire Resources, Hut 8, TeraWulf, MicroStrategy And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Friday's Top 5 Trending Stocks: What's The Scoop On GameStop, SoFi, Tesla?
GameStop, SoFi, Tesla, Cassava Sciences and Anavex Life Sciences are the top five trending stocks on Stocktwits Friday. Here's a look at what's going on: 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
AVXL Stock Earnings: Anavex Life Sciences Misses EPS for Q3 2024
AVXL stock results show that Anavex Life Sciences missed analyst estimates for earnings per share the third quarter of 2024. 
Via InvestorPlace
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Neurodegenerative Disease-Focused Anavex Life Sciences' Alzheimer's Candidate Slows Disease Progression By Almost 39%
Anavex Life Sciences presented Phase 2b/3 study results at AAIC 2024, showing daily oral blarcamesine (ANAVEX2-73) significantly slows clinical decline in early Alzheimer's disease. The 48-week study... 
Via Benzinga
Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
CrossFirst Bankshares Posts Q2 Earnings, Joins Owens & Minor, Reddit And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Why Match Group Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
GSK, Boston Beer And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
AVXL Stock Earnings: Anavex Life Sciences Misses EPS for Q2 2024
AVXL stock results show that Anavex Life Sciences missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.